Nike has lost its challenge to a Canberra AFL club’s trade mark, with IP Australia finding that the “arc-like feature” depicting a football in flight was not deceptively similar to the sportswear giant’s iconic swoosh mark.
The High Court has been asked to clarify the extent to which computer-implemented ideas are eligible for patent protection, with IP Australia appealing a win for gaming giant Aristocrat.
Puma has appealed its failed opposition to a trade mark for Tiger Woods’ golf apparel and equipment brand Sun Day Red, which the German sneaker giant argued was too similar to its iconic leaping cat mark.
Formalwear brand Portia & Scarlett, which has accused one of its founders of accessing confidential dress designs contained in two computer files, has asked a court for access to her personal devices.
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera’s bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.
A judge has declined car dealer software supplier Pentana’s bid to withdraw admissions made over four years ago in a dispute with competitor Titan DMS.
Samsung Bioepis has successfully opposed Janssen’s bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.
Abbey Animal Health has appealed its loss in a suit seeking to invalidate rival Virbac’s patent for an antiparasitic drug.
Green iron startup Element Zero is challenging a bid by Fortescue for access to nine million seized documents in their trade secrets spat, saying its rival has not met the test for proving inadequate discovery of material.
Abbey Animal Health has managed only a “pyrrhic victory” in a patent case against rival Virbac over an antiparasitic drug, and must withdraw its Levamox Duo product from the market, a court has found.